Abstract
The human trachea is a vital structure with complex architecture and well-defined mechanical properties. Trauma, neoplasm, congenital defects and iatrogenic injury can lead to loss of patency and necessitate surgical intervention to reestablish its function as a viable and disease resistant airway. Due to the trachea’s structural redundancy, and longitudinal elasticity, circumferential tracheal resection and primary anastomosis is safe in the majority of patients. For those who require removal of more than half of the trachea, options are limited. This unmet need, and the apparent simplicity of the trachea as a hollow tube, have inspired surgeons and scientists to engineer tracheal substitutes over nearly a century. None of these implants have achieved long term patency. As a result, patients have suffered from complications of premature clinical translation. While experimental research in this area has to continue, engineered tissues are not a viable form of treatment at this point in time.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belsey R. Resection and reconstruction of the intrathoracic trachea. Br J Surg. 1950;38:200–5.
Deslauriers J. Birth of airway surgery and evolution over the past fifty years. Thorac Surg Clin. 2018;28:109–15.
Grillo HC. Surgery of the trachea. Curr Probl Surg. 1970;7(7):3–59.
Grillo HC. Notes on the windpipe. Ann Thorac Surg. 1989;47:9–26.
Grillo HC. Tracheal replacement: a critical review. Ann Thorac Surg. 2002;73:1995–2004.
Udelsman B, Mathisen DJ, Ott HC. A reassessment of tracheal substitutes—a systematic review. Ann Cardiothorac Surg. 2018;7:175–82.
Cyranoski D. Investigations launched into artificial tracheas. Nature. 2014;516:16–7.
Delaere PR, Van Raemdonck D. The trachea: the first tissue-engineered organ? J Thorac Cardiovasc Surg. 2014;147:1128–32.
Roh JD, Sawh-Martinez R, Brennan MP, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A. 2010;107:4669–74.
Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–6.
Adamowicz J, Pokrywczynska M, Van Breda SV, Kloskowski T, Drewa T. Concise review: tissue engineering of urinary bladder; we still have a long way to go? Stem Cells Transl Med. 2017;6:2033–43.
Udelsman BV, Maxfield MW, Breuer CK. Tissue engineering of blood vessels in cardiovascular disease: moving towards clinical translation. Heart. 2013;99:454–60.
Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet. 2008;372:2023–30.
Jungebluth P, Alici E, Baiguera S, et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet. 2011;378:1997–2004.
Gonfiotti A, Jaus MO, Barale D, et al. The first tissue-engineered airway transplantation: 5-year follow-up results. Lancet. 2014;383:238–44.
Vogel G. Trachea transplants test the limits. Science. 2013;340:266–8.
Delaere P, Van Raemdonck D. Tracheal replacement. J Thorac Dis. 2016;8:S186–96.
Heckscher S, Carlberg I, Gahmberg C. Karolinska Institutet and the Macchiarini case. 2016. https://news.ki.se/sites/default/files/migrate/karolinska_institutet_and_the_macchiarini_case_summary_in_english_and_swedish.pdf. Accessed 12 Feb 2020.
Molins L. Patient follow-up after tissue-engineered airway transplantation. Lancet. 2019;393:1099.
Elliott MJ, De Coppi P, Speggiorin S, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet. 2012;380:994–1000.
Hamilton NJ, Kanani M, Roebuck DJ, et al. Tissue-engineered tracheal replacement in a child: a 4-year follow-up study. Am J Transplant. 2015;15:2750–7.
Elliott MJ, Butler CR, Varanou-Jenkins A, et al. Tracheal replacement therapy with a stem cell-seeded graft: lessons from compassionate use application of a GMP-compliant tissue-engineered medicine. Stem Cells Transl Med. 2017;6:1458–64.
Delaere P, Van Raemdonck D, Vranckx J. Tracheal transplantation. Intensive Care Med. 2019;45:391–3.
Delaere P, Vranckx J, Verleden G, De Leyn P, Van Raemdonck D, Leuven Tracheal Transplant Group. Tracheal allotransplantation after withdrawal of immunosuppressive therapy. N Engl J Med. 2010;362:138–45.
Delaere PR, Vranckx JJ, Meulemans J, et al. Learning curve in tracheal allotransplantation. Am J Transplant. 2012;12:2538–45.
Delaere PR, Vranckx JJ, Den Hondt M, Leuven Tracheal Transplant Group. Tracheal allograft after withdrawal of immunosuppressive therapy. N Engl J Med. 2014;370:1568–70.
Spaggiari L, Calabrese LS, D'Aiuto M, et al. Successful subtotal tracheal replacement (using a skin/omental graft) for dehiscence after a resection for thyroid cancer. J Thorac Cardiovasc Surg. 2005;129:1455–6.
Olias J, Millan G, da Costa D. Circumferential tracheal reconstruction for the functional treatment of airway compromise. Laryngoscope. 2005;115:159–61.
Fabre D, Kolb F, Fadel E, et al. Successful tracheal replacement in humans using autologous tissues: an 8-year experience. Ann Thorac Surg. 2013;96:1146–55.
Zhang S, Liu Z. Airway reconstruction with autologous pulmonary tissue flap and an elastic metallic stent. World J Surg. 2015;39:1981–5.
Thomet C, Modarressi A, Ruegg EM, Dulguerov P, Pittet-Cuenod B. Long-segment tracheal reconstruction with free radial forearm flap reinforced by rib cartilage. Ann Plast Surg. 2018;80:525–8.
Kolb F, Simon F, Gaudin R, et al. 4-Year follow-up in a child with a total autologous tracheal replacement. N Engl J Med. 2018;378:1355–7.
Hoffman TM, Gaynor JW, Bridges ND, Paridon SM, Spray TL. Aortic homograft interposition for management of complete tracheal anastomotic disruption after heart-lung transplantation. J Thorac Cardiovasc Surg. 2001;121:587–8.
Azorin JF, Bertin F, Martinod E, Laskar M. Tracheal replacement with an aortic autograft. Eur J Cardiothorac Surg. 2006;29:261–3.
Wurtz A, Porte H, Conti M, et al. Tracheal replacement with aortic allografts. N Engl J Med. 2006;355:1938–40.
Davidson MB, Mustafa K, Girdwood RW. Tracheal replacement with an aortic homograft. Ann Thorac Surg. 2009;88:1006–8.
Wurtz A, Porte H, Conti M, et al. Surgical technique and results of tracheal and carinal replacement with aortic allografts for salivary gland-type carcinoma. J Thorac Cardiovasc Surg. 2010;140:387–93 e2.
Martinod E, Paquet J, Dutau H, et al. In vivo tissue engineering of human airways. Ann Thorac Surg. 2017;103:1631–40.
Bolton WD, Ben-Or S, Hale AL, Stephenson JE. Reconstruction of a long-segment tracheal defect using an alloderm conduit. Innovations (Phila). 2017;12:137–9.
Martinod E, Chouahnia K, Radu DM, et al. Feasibility of bioengineered tracheal and bronchial reconstruction using stented aortic matrices. JAMA. 2018;319:2212–22.
Delaere P, Lerut T, Van Raemdonck D. Tracheal transplantation: state of the art and key role of blood supply in its success. Thorac Surg Clin. 2018;28:337–45.
STMD: Centennial Challenges. 2019. https://www.nasa.gov/directorates/spacetech/centennial_challenges/vascular_tissue.html. Accessed 2 Nov 2019.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Udelsman, B.V., Ott, H.C. (2020). Are Engineered Tissues Useful for Tracheal Reconstruction?. In: Ferguson, M. (eds) Difficult Decisions in Thoracic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-47404-1_46
Download citation
DOI: https://doi.org/10.1007/978-3-030-47404-1_46
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-47403-4
Online ISBN: 978-3-030-47404-1
eBook Packages: MedicineMedicine (R0)